PT  - JOURNAL ARTICLE
AU  - Bedford, Trevor
AU  - Greninger, Alexander L.
AU  - Roychoudhury, Pavitra
AU  - Starita, Lea M.
AU  - Famulare, Michael
AU  - Huang, Meei-Li
AU  - Nalla, Arun
AU  - Pepper, Gregory
AU  - Reinhardt, Adam
AU  - Xie, Hong
AU  - Shrestha, Lasata
AU  - Nguyen, Truong N
AU  - Adler, Amanda
AU  - Brandstetter, Elisabeth
AU  - Cho, Shari
AU  - Giroux, Danielle
AU  - Han, Peter D.
AU  - Fay, Kairsten
AU  - Frazar, Chris D.
AU  - Ilcisin, Misja
AU  - Lacombe, Kirsten
AU  - Lee, Jover
AU  - Kiavand, Anahita
AU  - Richardson, Matthew
AU  - Sibley, Thomas R.
AU  - Truong, Melissa
AU  - Wolf, Caitlin R.
AU  - Nickerson, Deborah A.
AU  - Rieder, Mark J.
AU  - Englund, Janet A.
AU  - ,
AU  - Hadfield, James
AU  - Hodcroft, Emma B.
AU  - Huddleston, John
AU  - Moncla, Louise H.
AU  - Müller, Nicola F.
AU  - Neher, Richard A.
AU  - Deng, Xianding
AU  - Gu, Wei
AU  - Federman, Scot
AU  - Chiu, Charles
AU  - Duchin, Jeff
AU  - Gautom, Romesh
AU  - Melly, Geoff
AU  - Hiatt, Brian
AU  - Dykema, Philip
AU  - Lindquist, Scott
AU  - Queen, Krista
AU  - Tao, Ying
AU  - Uehara, Anna
AU  - Tong, Suxiang
AU  - MacCannell, Duncan
AU  - Armstrong, Gregory L.
AU  - Baird, Geoffrey S.
AU  - Chu, Helen Y.
AU  - Shendure, Jay
AU  - Jerome, Keith R.
TI  - Cryptic transmission of SARS-CoV-2 in Washington State
AID  - 10.1101/2020.04.02.20051417
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.04.02.20051417
4099  - http://medrxiv.org/content/early/2020/04/06/2020.04.02.20051417.short
4100  - http://medrxiv.org/content/early/2020/04/06/2020.04.02.20051417.full
AB  - Following its emergence in Wuhan, China, in late November or early December 2019, the SARS-CoV-2 virus has rapidly spread throughout the world. On March 11, 2020, the World Health Organization declared Coronavirus Disease 2019 (COVID-19) a pandemic (1). Genome sequencing of SARS-CoV-2 strains allows for the reconstruction of transmission history connecting these infections. Here, we analyze 346 SARS-CoV-2 genomes from samples collected between 20 February and 15 March 2020 from infected patients in Washington State, USA. We found that the large majority of SARS-CoV-2 infections sampled during this time frame appeared to have derived from a single introduction event into the state in late January or early February 2020 and subsequent local spread, strongly suggesting cryptic spread of COVID-19 during the months of January and February 2020, before active community surveillance was implemented. We estimate a common ancestor of this outbreak clade as occurring between 18 January and 9 February 2020. From genomic data, we estimate an exponential doubling between 2.4 and 5.1 days. These results highlight the need for large-scale community surveillance for SARS-CoV-2 introductions and spread and the power of pathogen genomics to inform epidemiological understanding.Competing Interest StatementJanet A. Englund is a consultant for Sanofi Pasteur and Meissa Vaccines, Inc., and receives research support from GlaxoSmithKline, AstraZeneca, and Novavax. Helen Chu is a consultant for Merck and GlaxoSmithKline. Jay Shendure is a consultant with Guardant Health, Maze Therapeutics, Camp4 Therapeutics, Nanostring, Phase Genomics, Adaptive Biotechnologies, and Stratos Genomics, and has a research collaboration with Illumina. Michael Famulare, Lea Starita, Pavitra Roychoudhury, Amanda Adler, Peter Han, Kirsten Lacombe, Elisabeth Brandstetter, Caitlin R. Wolf, Richard A Neher, James Hadfield, Nicola F. Müller, Jover Lee, Thomas Sibley, Kairsten Fay, Deborah A. Nickerson, Mark J. Rieder, and Trevor Bedford declare no competing interests.Funding StatementThe Seattle Flu Study is run through the Brotman Baty Institute for Precision Medicine and funded by Gates Ventures, the private office of Bill Gates. The funder was not involved in the design of the study and does not have any ownership over the management and conduct of the study, the data, or the rights to publish. JS is an Investigator of the Howard Hughes Medical Institute. TB is a Pew Biomedical Scholar and is supported by NIH R35 GM119774-01. EBH and RAN are supported by University of Basel core funding. Sequencing analyses of SARS-CoV-2 genomes from California was supported by an NIH grant R33-AI129455 and the Charles and Helen Schwab Foundation to CYC, and an NIH grant K08-CA230156 and the Burroughs-Wellcome CAMS Award to WG. Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesConsensus SARS-CoV-2 genome sequences were deposited into GISAID immediately on generation. They have been submitted to Genbank as well (accession pending). All data used in the paper is also available here: https://github.com/blab/ncov-cryptic-transmission.